MicroRNA‑3148 inhibits glioma by decreasing <em>DCUN1D1</em> and inhibiting the NF‑kB pathway

Xu,Qianghua; Chen,Xiao; Chen,Bin

doi:10.3892/etm.2021.10950

MicroRNA‑3148 inhibits glioma by decreasing DCUN1D1 and inhibiting the NF‑kB pathway

Authors:
- Qianghua Xu
- Xiao Chen
- Bin Chen
View Affiliations

Affiliations: Department of Neurosurgery, The First People's Hospital of Jingmen, Jingmen, Hubei 448000, P.R. China, Department of Neurosurgery, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei 441021, P.R. China
Published online on: November 8, 2021 https://doi.org/10.3892/etm.2021.10950
Article Number: 28
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glioma, which originates in the brain, is the most aggressive tumor of the central nervous system. It has been shown that microRNA (miRNA) controls the proliferation, migration and apoptosis of glioma cells. The objective of the present study was to measure microRNA‑3148 (miR‑3148) expression and investigate its impact on the pathogenetic mechanism of glioma. In the present study, reverse transcription‑quantitative real‑time PCR was employed to detect miR‑3148 expression levels in glioma tissues and cell lines. Cell Counting Kit‑8 assay, 5‑ethynyl‑2'‑deoxyuridine assay, and Transwell migration assay were performed to assess the influence of miR‑3148 on the malignant biological behavior of glioma cells. The biological functions of miR‑3148 in glioma were examined via a xenograft tumor growth assay. Furthermore, the association between miR‑3148 and DCUN1D1 was investigated via immunohistochemistry, dual‑luciferase reporter assay and western blotting. It was observed that miR‑3148 was expressed at low levels in glioma cells, and this represented a poor survival rate. In addition, an increased level of miR‑3148 in cells and animal models inhibited glioma cell migration and proliferation. Moreover, miR‑3148 decreased DCUN1D1 and curbed the nuclear factor κ enhancer binding protein (NF‑κB) signaling pathway, thus decreasing the growth of glioma. Thus, miR‑3148 is expressed within glioma tissues at low levels where it suppresses glioma by curbing the NF‑κB pathway and lowering DCUN1D1.

View Figures

View References

1	Rynkeviciene R, Simiene J, Strainiene E, Stankevicius V, Usinskiene J, Kaubriene EM, Meskinyte I, Cicenas J and Suziedelis K: Non-coding RNAs in glioma. Cancers (Basel). 11(17)2018.PubMed/NCBI View Article : Google Scholar
2	Chen Y, Bao C, Zhang X, Lin X, Huang H and Wang Z: Long non-coding RNA HCG11 modulates glioma progression through cooperating with miR-496/CPEB3 axis. Cell Prolif. 52(e12615)2019.PubMed/NCBI View Article : Google Scholar
3	Zheng Y, Lu S, Xu Y and Zheng J: Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating wnt/beta-catenin signaling pathway. Int J Biol Macromol. 128:521–530. 2019.PubMed/NCBI View Article : Google Scholar
4	Zhou Z, Huang R, Chai R, Zhou X, Hu Z, Wang W, Chen B, Deng L, Liu Y and Wu F: Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma. Aging (Albany NY). 10:3185–3209. 2018.PubMed/NCBI View Article : Google Scholar
5	Cheng M, Zhang ZW, Ji XH, Xu Y, Bian E and Zhao B: Super-enhancers: A new frontier for glioma treatment. Biochim Biophys Acta Rev Cancer. 1873(188353)2020.PubMed/NCBI View Article : Google Scholar
6	Kundu M, Das S, Dhara D and Mandal M: Prospect of natural products in glioma: A novel avenue in glioma management. Phytother Res. 33:2571–2584. 2019.PubMed/NCBI View Article : Google Scholar
7	Yan C, Wang J, Yang Y, Ma W and Chen X: Molecular biomarker-guided anti-angiogenic targeted therapy for malignant glioma. J Cell Mol Med. 23:4876–4882. 2019.PubMed/NCBI View Article : Google Scholar
8	Cao H, Li X, Wang F, Zhang Y, Xiong Y and Yang Q: Phytochemical-mediated glioma targeted treatment: Drug resistance and novel delivery systems. Curr Med Chem. 27:599–629. 2020.PubMed/NCBI View Article : Google Scholar
9	Orellana EA, Li C, Lisevick A and Kasinski AL: Identification and validation of microRNAs that synergize with miR-34a-a basis for combinatorial microRNA therapeutics. Cell Cycle. 18:1798–1811. 2019.PubMed/NCBI View Article : Google Scholar
10	Pereira TD, Brito JAR, Guimarães ALS, Gomes CC, de Lacerda JC, de Castro WH, Coimbra RS, Diniz MG and Gomez RS: MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma. J Oral Pathol Med. 47:78–85. 2018.PubMed/NCBI View Article : Google Scholar
11	Witwer KW and Halushka MK: Toward the promise of microRNAs-enhancing reproducibility and rigor in microRNA research. RNA Biol. 13:1103–1116. 2016.PubMed/NCBI View Article : Google Scholar
12	Seo HA, Moeng S, Sim S, Kuh HJ, Choi SY and Park JK: MicroRNA-based combinatorial cancer therapy: Effects of microRNAs on the efficacy of anti-cancer therapies. Cells. 9(29)2019.PubMed/NCBI View Article : Google Scholar
13	Koufaris C: Human and primate-specific microRNAs in cancer: Evolution, and significance in comparison with more distantly-related research models: The great potential of evolutionary young microRNA in cancer research. Bioessays. 38:286–294. 2016.PubMed/NCBI View Article : Google Scholar
14	Sakaue S, Hirata J, Maeda Y, Kawakami E, Nii T, Kishikawa T, Ishigaki K, Terao C, Suzuki K, Akiyama M, et al: Integration of genetics and miRNA-target gene network identified disease biology implicated in tissue specificity. Nucleic Acids Res. 46:11898–11909. 2018.PubMed/NCBI View Article : Google Scholar
15	Yan D, Hao C, Xiao-Feng L, Yu-Chen L, Yu-Bin F and Lei Z: Molecular mechanism of notch signaling with special emphasis on microRNAs: Implications for glioma. J Cell Physiol. 234:158–170. 2018.PubMed/NCBI View Article : Google Scholar
16	Peng Y, Wang X, Guo Y, Peng F, Zheng N, He B, Ge H, Tao L and Wang Q: Pattern of cell-to-cell transfer of microRNA by gap junction and its effect on the proliferation of glioma cells. Cancer Sci. 110:1947–1958. 2019.PubMed/NCBI View Article : Google Scholar
17	Xu H, Zhao G, Zhang Y, Jiang H, Wang W, Zhao D, Hong J, Yu H and Qi L: Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via wnt/β-catenin signaling pathway by targeting EZH2. Stem Cell Res Ther. 10(381)2019.PubMed/NCBI View Article : Google Scholar
18	Wang H and Xie Y: BRD7-mediated miR-3148 inhibits progression of cervical cancer by targeting wnt3a/β-catenin pathway. Reprod Sci. 27:877–887. 2020.PubMed/NCBI View Article : Google Scholar
19	Liu S, Yin F, Zhang J, Wicha MS, Chang AE, Fan W, Chen L, Fan M and Li Q: Regulatory roles of miRNA in the human neural stem cell transformation to glioma stem cells. J Cell Biochem. 115:1368–1380. 2014.PubMed/NCBI View Article : Google Scholar
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2004.PubMed/NCBI View Article : Google Scholar
21	Broderick SR, Golas BJ, Pham D, Towe CW, Talbot SG, Kaufman A, Bains S, Huryn LA, Yonekawa Y, Carlson D, et al: SCCRO promotes glioma formation and malignant progression in mice. Neoplasia. 12:476–484. 2010.PubMed/NCBI View Article : Google Scholar
22	Tan C, Liu L, Liu X, Qi L, Wang W, Zhao G, Wang L and Dai Y: Activation of PTGS2/NF-κB signaling pathway enhances radiation resistance of glioma. Cancer Med. 8:1175–1185. 2019.PubMed/NCBI View Article : Google Scholar
23	Geeviman K, Babu D and Babu PP: Pantoprazole induces mitochondrial apoptosis and attenuates NF-κB signaling in glioma cells. Cell Mol Neurobiol. 38:1491–1504. 2018.PubMed/NCBI View Article : Google Scholar
24	Ius T, Ciani Y, Ruaro ME, Isola M, Sorrentino M, Bulfoni M, Candotti V, Correcig C, Bourkoula E, Manini I, et al: An NF-κB signature predicts low-grade glioma prognosis: A precision medicine approach based on patient-derived stem cells. Neuro Oncol. 20:776–787. 2018.PubMed/NCBI View Article : Google Scholar
25	Hou G, Xu W, Jin Y, Wu J, Pan Y and Zhou F: MiRNA-217 accelerates the proliferation and migration of bladder cancer via inhibiting KMT2D. Biochem Biophys Res Commun. 519:747–753. 2019.PubMed/NCBI View Article : Google Scholar
26	Wang R, Sun Y, Yu W, Qiao M, Jiang R, Guan W and Wang L: Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT. J Exp Clin Cancer Res. 38(20)2019.PubMed/NCBI View Article : Google Scholar
27	Hetta HF, Zahran AM, Shafik EA, El-Mahdy RI, Mohamed NA, Nabil EE, Esmaeel HM, Alkady OA, Elkady A, Mohareb DA, et al: Circulating miRNA-21 and miRNA-23a expression signature as potential biomarkers for early detection of non-small-cell lung cancer. Microrna. 8:206–215. 2019.PubMed/NCBI View Article : Google Scholar
28	Zhou Q, Liu J, Quan J, Liu W, Tan H and Li W: MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis. Cancer Sci. 109:2651–2659. 2018.PubMed/NCBI View Article : Google Scholar
29	Cheng W, Ren X, Zhang C, Han S and Wu A: Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status. J Neurooncol. 132:207–218. 2017.PubMed/NCBI View Article : Google Scholar
30	Xiong W, Ran J, Jiang R, Guo P, Shi X, Li H, Lv X, Li J and Chen D: miRNA-320a inhibits glioma cell invasion and migration by directly targeting aquaporin 4. Oncol Rep. 39:1939–1947. 2018.PubMed/NCBI View Article : Google Scholar
31	Huntzinger E and Izaurralde E: Gene silencing by microRNAs: Contributions of translational repression and mRNA decay. Nat Rev Genet. 12:99–110. 2011.PubMed/NCBI View Article : Google Scholar
32	Kim AY, Bommeljé CC, Lee BE, Yonekawa Y, Choi L, Morris LG, Huang G, Kaufman A, Ryan RJ, Hao B, et al: SCCRO (DCUN1D1) is an essential component of the E3 complex for neddylation. J Biol Chem. 283:33211–33220. 2008.PubMed/NCBI View Article : Google Scholar
33	Huang G, Kaufman AJ, Ramanathan Y and Singh B: SCCRO (DCUN1D1) promotes nuclear translocation and assembly of the neddylation E3 complex. J Biol Chem. 286:10297–10304. 2011.PubMed/NCBI View Article : Google Scholar
34	Sarkaria I, O-charoenrat P, Talbot SG, Reddy PG, Ngai I, Maghami E, Patel KN, Lee B, Yonekawa Y, Dudas M, et al: Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas. Cancer Res. 66:9437–9444. 2006.PubMed/NCBI View Article : Google Scholar
35	O-charoenrat P, Sarkaria I, Talbot SG, Reddy P, Dao S, Ngai I, Shaha A, Kraus D, Shah J, Rusch V, et al: SCCRO (DCUN1D1) induces extracellular matrix invasion by activating matrix metalloproteinase 2. Clin Cancer Res. 14:6780–6789. 2008.PubMed/NCBI View Article : Google Scholar
36	Williams LM and Gilmore TD: Looking down on NF-κB. Mol Cell Biol. 40:e00104–e00120. 2020.PubMed/NCBI View Article : Google Scholar
37	Zhou L, Deng ZZ, Li HY, Jiang N, Wei ZS, Hong MF, Chen XD, Wang JH, Zhang MX, Sh YH, et al: TRIM31 promotes glioma proliferation and invasion through activating NF-κB pathway. Onco Targets Ther. 12:2289–2297. 2019.PubMed/NCBI View Article : Google Scholar
38	Zhou Y, Tan Z, Chen K, Wu W, Zhu J, Wu G, Cao L, Zhang X, Zeng X, Li J and Zhang W: Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-κB signaling pathway. Mol Carcinog. 57:1181–1190. 2018.PubMed/NCBI View Article : Google Scholar
39	Hai L, Liu P, Yu S, Yi L, Tao Z, Zhang C, Abeysekera IR, Li T, Tong L, Ma H, et al: Jagged1 is clinically prognostic and promotes invasion of glioma-initiating cells by activating NF-κB(p65) signaling. Cell Physiol Biochem. 51:2925–2937. 2018.PubMed/NCBI View Article : Google Scholar